Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7226990 Extendin derivatives

Patent 7226990 was granted and assigned to Novo Nordisk on June, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11884713 Acylated glucagon analogues
0
Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11788066 Antibody conjugates and methods of making and using the same
Edits on 16 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Kjeld Madsen0
Liselotte Bjerre Knudsen0
Per Franklin Nielsen0
Per Olaf Huusfeldt0
Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11752198 GLP-1 compositions and uses thereof
Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+297 characters)
Article

Patent abstract

The present invention relates to novel derivatives of exendin-4 or exendin-4 fragments, wherein the derivatives have a lipophilic substituent attached, optionally via a spacer, to an amino acid residue, which is not the N-terminal or C-terminal amino acid residue of the derivative.

Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07226990 Extendin derivatives US Patent 7226990 Extendin derivatives

Infobox
Patent Number
072269900
Patent Number
72269900
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072269900
Edits on 28 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072269900
Date of Patent
June 5, 2007
0
Patent Application Number
098863110
Date Filed
June 21, 2001
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072269900
Patent Primary Examiner
‌
Jon Weber
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07226990
Edits on 21 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07226990 Extendin derivatives

Infobox
Is a
Patent
Patent
Current assignee
Novo Nordisk
Novo Nordisk
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07226990
Date of patent
June 5, 2007
Patent application number
09886311
Date Filed
June 21, 2001
Patent primary examiner
‌
Jon Weber

Find more entities like US Patent 7226990 Extendin derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo